Table 1.

Clinicopathological characteristics of the study population.

Characteristics	Total number of patients (N = 82)
Stage
I	32
II	26
III	24
T stage
T1	50
T2	27
T3	2
T4	3
N stage
N0	43
N1	21
N2	10
N3	8
Histology
Invasive ductal carcinoma	79
Invasive lobular carcinoma	3
Histologic grade
G1	18
G2	42
G3	11
Unidentified	11
Chemotherapy regimen
Anthracycline + cyclophosphamide	42
Anthracycline + cyclophosphamide followed by taxane	27
Anthracycline + taxane (to be continued)	13
Operation
Total mastectomy	22
Breast conserving surgery	60
BMI
<27	69
≥27	13
ASTRRA trial group
Menopause for 2 years, tamoxifen only	6
Ovarian function resumption, tamoxifen only	37
Ovarian function resumption, tamoxifen combining ovarian function suppression by GnRH agonist	39

GnRH agonist, gonadotropin-releasing hormone agonist.